Sign In
Buy TNDM
$18.03
-0.570 (-3.06%)
At Close: Jun 03, 2026
Tandem Diabetes Care, Inc. (TNDM) Q1 2023 Earnings Call Transcript
11:42pm, Wednesday, 03'rd May 2023
Tandem Diabetes Care, Inc. (NASDAQ:TNDM ) Q1 2023 Earnings Conference Call May 3, 2023 4:30 PM ET Company Participants Susan Morrison - Executive Vice President and Chief Administrative Officer John S
Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Lags Revenue Estimates
07:02pm, Wednesday, 03'rd May 2023
Tandem Diabetes Care, Inc. (TNDM) came out with a quarterly loss of $0.63 per share versus the Zacks Consensus Estimate of a loss of $0.56. This compares to loss of $0.23 per share a year ago.
2 Beaten-Down Growth Stocks to Buy in April
09:45am, Thursday, 20'th Apr 2023
Axsome is expecting important developments that should improve its already-bright prospects. Tandem's innovative insulin pump should allow it to capture a larger share of the diabetes market.
Tandem Diabetes Care to Announce First Quarter 2023 Financial Results on May 3, 2023
04:05pm, Tuesday, 11'th Apr 2023
SAN DIEGO--(BUSINESS WIRE)-- #TandemDiabetes--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2023 results aft
Tandem Diabetes (TNDM) Gains on Pump Sales, Margin Woe Stays
12:55pm, Monday, 03'rd Apr 2023
Tandem Diabetes (TNDM) is now increasing its renewal numbers both in volume and rates.
Tandem Diabetes (TNDM) Releases Favorable Data on t:slim X2
04:49pm, Friday, 17'th Mar 2023
Tandem Diabetes (TNDM) demonstrated positive results from the clinical trial of advancing its Control-IQ technology to younger age group patients.
This Stock Could Soar By as Much as 106%, According to Wall Street
10:00am, Sunday, 05'th Mar 2023
Tandem Diabetes Care is having issues on the top and bottom lines. However, the medical device maker still boasts plenty of growth avenues.
Tandem Diabetes (TNDM) Q4 Earnings Beat, Gross Margin Dips
12:03pm, Thursday, 23'rd Feb 2023
Tandem Diabetes (TNDM) Q4 GAAP sales reflect an accounting deferral related to the recent introduction of the company's Tandem Choice program in the United States.
Tandem Diabetes Care, Inc. (TNDM) Q4 2022 Earnings Call Transcript
07:41pm, Wednesday, 22'nd Feb 2023
Tandem Diabetes Care, Inc. (NASDAQ:TNDM ) Q4 2022 Earnings Conference Call February 22, 2023 4:30 PM ET Company Participants Susan Morrison - EVP & Chief Administrative Officer John Sheridan - Preside
Tandem Diabetes Care, Inc. (TNDM) Reports Q4 Loss, Misses Revenue Estimates
07:34pm, Wednesday, 22'nd Feb 2023
Tandem Diabetes Care, Inc. (TNDM) delivered earnings and revenue surprises of 50% and 1.06%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the sto
Tandem Diabetes Care Announces Upcoming Conference Presentations
04:05pm, Wednesday, 15'th Feb 2023
SAN DIEGO--(BUSINESS WIRE)---- $TNDM #TNDM--Tandem Diabetes Care, Inc.
Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2022 Financial Results on February 22, 2023
04:05pm, Thursday, 19'th Jan 2023
SAN DIEGO--( BUSINESS WIRE )--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2022 results afte
Tandem Diabetes stock rises after preliminary sales hit reduced guidance, 2023 forecast exceeds mark
04:29pm, Tuesday, 10'th Jan 2023
Tandem Diabetes Inc. TNDM, -1.55% shares gained nearly 7% in after-hours trading Tuesday, following preliminary quarterly sales information that lived up to reduced guidance from the company. Tandem d
2 Stocks Down 72% or More to Buy in 2023 and Hold for 10 Years
09:15am, Saturday, 24'th Dec 2022
These companies' shareholders will have the last laugh.
Tandem (TNDM) to Expand Global Insulin Pump Base With New Buy
10:32am, Monday, 19'th Dec 2022
The AMF Medical acquisition will help Tandem (TNDM) advance with its sustainability objectives by offering an additional pump that minimizes electronic and battery waste generation.
